![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/864258/salix-to-present-late-breaking-data-from-phase-2-trial-of-amiselimod-in-active-ulcerative-colitis-at-digestive-disease-week-2024
https://www.fiercepharma.com/marketing/salix-adds-melody-xifaxan-campaign-running-tv-spot-scandal-actor-bellamy-young
https://www.accesswire.com/861131/salix-pharmaceuticals-announces-bellamy-young-as-spokesperson-for-xifaxan-rifaximin
https://www.accesswire.com/839567/salix-pharmaceuticals-announces-a-phase-2-investigator-initiated-study-of-relistor-methylnaltrexone-bromide-mntx-in-patients-with-resectable-head-and-neck-squamous-cell-carcinoma
https://www.fiercepharma.com/marketing/salix-seeking-tackle-stigma-co-creates-awareness-day-opioid-induced-constipation
https://endpts.com/bausch-healths-salix-initiates-first-awareness-day-for-opioid-induced-constipation/
https://www.fiercepharma.com/pharma/alvogens-bid-force-fda-approve-generic-bausch-healths-ibd-d-med-xifaxan-shot-down-dc-court